Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. [electronic resource]
Producer: 20031219Description: 623-36 p. digitalISSN:- 0028-3908
- 1-Methyl-3-isobutylxanthine -- pharmacology
- Amphibian Proteins
- Amyloid beta-Peptides -- pharmacology
- Animals
- Animals, Newborn
- Apoptosis
- Blotting, Western -- methods
- Cell Survival -- drug effects
- Cells, Cultured
- Cerebellum
- Cerebral Cortex -- drug effects
- Chromatin -- metabolism
- Chromones -- pharmacology
- Colforsin -- pharmacology
- Corticotropin-Releasing Hormone -- antagonists & inhibitors
- Cyclic AMP -- analogs & derivatives
- Dose-Response Relationship, Drug
- Drug Interactions
- Enzyme Inhibitors -- pharmacology
- Enzyme-Linked Immunosorbent Assay -- methods
- Glycogen Synthase Kinase 3 -- metabolism
- Hippocampus -- drug effects
- In Situ Nick-End Labeling -- methods
- Inhibitory Concentration 50
- L-Lactate Dehydrogenase -- metabolism
- Mitogen-Activated Protein Kinase Kinases -- metabolism
- Morpholines -- pharmacology
- Neurons -- drug effects
- Neuroprotective Agents -- pharmacology
- Peptide Fragments -- pharmacology
- Peptide Hormones
- Peptides -- pharmacology
- Phosphorylation -- drug effects
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins -- metabolism
- Proto-Oncogene Proteins c-akt
- Pyrimidines -- pharmacology
- Pyrroles -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Receptors, Corticotropin-Releasing Hormone -- metabolism
- Thionucleotides -- pharmacology
- Time Factors
- Urocortins
- Urotensins -- pharmacology
- Vasodilator Agents -- pharmacology
- CRF Receptor, Type 1
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.